ACUTE AND CHRONIC THERAPEUTIC IMPACT OF A VASOPRESSIN ANTAGONIST IN CONGESTIVE HEART FAILURE (ACTIV IN CHF) INVESTIGATORS. EFFECTS OF TOLVAPTAN, A VASOPRESSIN ANTAGONIST, IN PATIENTS HOSPITALIZED WITH WORSENING HEART FAILURE: A RANDOMIZED CONTROLLED TRIAL
暂无分享,去创建一个
M. Gheorghiade | K. Adams | R. Benza | J. Ghali | J. Ouyang | C. Orlandi | A. Barbagelata | W. Gattis | F. Mcgrew | M. Klapholz | C. O. Connor | U. Kayam | Alejandro Barbagelata